Selvita is a Poland-based integrated drug discovery and development service provider (CRO) with expanding CDMO capabilities following its 2024 acquisition of PozLab. The company offers comprehensive services spanning drug discovery (medicinal chemistry, pharmacology, DMPK, protein sciences), drug development (analytical, formulation, clinical trial batch manufacturing), and contract testing under GMP/GLP. Selvita has operations in Krakow, Poznan, and Wroclaw (Poland) and Zagreb (Croatia).
drug discovery services, medicinal chemistry, DMPK, analytical development, formulation development, small molecule and biologics drug development
2 sites worldwide
No reviews available yet.
No documents available.